Hypoalbuminemia and hypercalcemia are independently associated with poor treatment outcomes of anti-PD-1 immune checkpoint inhibitors in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Saved in:
| Title: | Hypoalbuminemia and hypercalcemia are independently associated with poor treatment outcomes of anti-PD-1 immune checkpoint inhibitors in patients with recurrent or metastatic head and neck squamous cell carcinoma. |
|---|---|
| Authors: | Chiu, Tai-Jan1 (AUTHOR), Huang, Tai-Lin1 (AUTHOR), Chien, Chih-Yen2 (AUTHOR), Huang, Wan-Ting3 (AUTHOR), Li, Shau-Hsuan1 (AUTHOR) lee.a0928@msa.hinet.net |
| Source: | World Journal of Surgical Oncology. 9/11/2024, Vol. 22 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14777819 |
|---|---|
| DOI: | 10.1186/s12957-024-03522-2 |
